RichardSanfordFinkelMD

Child Neurology • Memphis, TN

Neuromuscular Medicine

Director, Center for Experimental Neurotherapeutics at St. Jude Children's Research Hospital

Join to view full profile

Dr. Finkel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Finkel's full profile

Already have an account?

Office
St. Jude Children's Research Hospital
262 Danny Thomas Place
Memphis, TN 38105

Education & Training

Boston Children’s Hospital/Beth Israel Deaconess Medical Center/Harvard Medical SchoolFellowship, Child Neurology, 1980 - 1983
Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1978 - 1980
Washington University in St. Louis School of MedicineClass of 1978

Certifications & Licensure

FL State Medical License 2012 - 2026
IL State Medical License 2023 - 2026
TN State Medical License 2020 - 2026
AL State Medical License 2023 - 2025
GA State Medical License 2023 - 2025
KY State Medical License 2023 - 2025
LA State Medical License 2023 - 2025
MS State Medical License 2023 - 2025
PA State Medical License 1999 - 2014
CO State Medical License 1983 - 2001
American Board of Pediatrics Pediatrics
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
American Board of Psychiatry and Neurology Neuromuscular Medicine
Join now to see all

Clinical Trials

Safety and Efficacy Study of PTC124 in Duchenne Muscular Dystrophy Start of enrollment: 2005 Dec 01
Completed
Phase 2
A Pilot Study of Biomarkers for Spinal Muscular Atrophy Start of enrollment: 2008 Oct 01
Completed
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others Start of enrollment: 2010 Apr 01
Recruiting
Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2 Start of enrollment: 2010 May 01
Recruiting
Development of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMT Start of enrollment: 2010 Apr 01
Recruiting
Finding the Optimum Regimen for Duchenne Muscular Dystrophy Start of enrollment: 2013 Jan 01
Completed
Phase 3
A Study of Tadalafil for Duchenne Muscular Dystrophy Start of enrollment: 2013 Sep 01
Terminated
Phase 3
Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy Start of enrollment: 2014 Apr 17
Completed
Phase 2
A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Infants With Spinal Muscular Atrophy Start of enrollment: 2014 Aug 19
Terminated
Phase 3
Genetics of Pediatric-Onset Motor Neuron and Neuromuscular Diseases Start of enrollment: 2015 Jun 01
Recruiting
Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy Start of enrollment: 2017 Jun 06
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

1 citations
TRPV4 neuromuscular disease registry highlights bulbar, skeletal and proximal limb manifestations.
Gage P Kosmanopoulos, Jack K Donohue, Maya Hoke, Simone Thomas, Margo A Peyton
Brain. 2025-01-07
Outcomes for patients in the RESTORE registry with spinal muscular atrophy and four or more SMN2 gene copies treated with onasemnogene abeparvovec.
Eduardo F Tizzano, Susana Quijano-Roy, Laurent Servais, Julie A Parsons, Sharon Aharoni
European Journal of Paediatric Neurology. 2024-11-01
Upper limb function changes over 12 months in untreated SMA II and III individuals: an item-level analysis using the Revised Upper Limb Module.
Giorgia Coratti, Matthew Civitello, Annemarie Rohwer, Emilio Albamonte, Jacqueline Montes
Neuromuscular Disorders. 2024-11-01

Press Mentions

Alcyone Wins Breakthrough Device Status for Delivery DeviceMarch 11th, 2019
Drug to Treat 'Floppy Baby Syndrome' Takes Home Multi-Million Dollar Prize at the 'Oscars for Science'October 17th, 2018
Final Phase 3 Study Data Show SPINRAZAApril 24th, 2017
Join now to see all